Research library
The research library
Every primary source behind a claim on this site, tier-graded for provenance and tagged for the strength of the evidence it carries.
- Sources indexed
- 221
- Peptides covered
- 44
- Tier 1 share
- 0%
- Matching filter
- 1
F·Filter
Reset allT3·Expert-primary work
Domain-expert primary sources outside the journal pipeline — lectures, podcasts, position papers.
1 source
- 2005Opinionanecdotaln=300
The effect of AOD9604 on weight loss in obese adults: results of a randomized, double-blind, placebo-controlled, multicenter study
Herd C, Wittert G, Caterson L, +6 · Obesity Research (NAASO Annual Meeting conference proceedings)
The Phase IIa AOD-9604 data — the 1 mg oral dose producing roughly 2.6–2.8 kg weight loss versus 0.8 kg on placebo across 12 weeks in 300 obese adults — was presented as a NAASO conference abstract in 2005 and never developed into a peer-reviewed full-paper publication. The marketing literature in 2026 still cites it as primary evidence.